| 货号 | 61266S |
| 同种亚型 | Rabbit IgG |
| 反应种属 | Human\Moneky |
| 来源宿主 | Rabbit IgG |
| 应用 | WB |
| 目标/特异性 | UBE1L/UBA7 (D6U4S) Rabbit mAb recognizes endogenous levels of total UBE1L/UBA7 protein. This antibody does not cross-react with either UBE1/UBA1 or UBE1L2/UBA6 proteins. |
| 使用方法 | W |
| 供应商 | CST |
| 灵敏度 | Endogenous |
| 背景 | Interferon-stimulated 15 kDa protein (ISG15), also known as ubiquitin cross-reactive protein (UCRP), is a member of the ubiquitin-like protein family and functions in various biological pathways from pregnancy to innate immune responses (1). Expression of ISG15 is stimulated by cellular exposure to type 1 interferons α and β, in addition to infection with viruses such as influenza B (2,3). After exposure to type I interferons, both lymphocytes and monocytes, in addition to some fibroblasts and epithelial cells, release ISG15 into culture medium (1,4). ISG15 has been shown to function as a cytokine, stimulating interferon γ secretion by monocytes and macrophages, proliferation of natural killer cells, and chemotactic responses in neutrophils (4,5). ISG15 has also been shown to function intracellularly, being covalently conjugated to other proteins by E1 (Ube1L), E2 (UbcH8) and E3 ligases via a multi-step process analogous to ubiquitination (6,7). ISG15 is removed from proteins by the ubiquitin processing protease Ubp43 (8). ISG15-protein conjugation (ISGylation) is induced by type 1 interferons, and target proteins include the serine protease inhibitor Serpin 2A, PLCγ1, ERK1/2, Jak1 and Stat1 (9,10). Unlike ubiquitination, ISGylation does not target proteins for degradation, rather ISGylation increases Jak1 and Stat1 activity, enhancing the cellular response to interferons (11). |
| 存放说明 | -20C |
| 计算分子量 | 110 |
| 参考文献 | 1 . Ritchie, K.J. and Zhang, D.E. (2004) Semin. Cell Dev. Biol. 15, 237-246. 2 . Korant, B.D. et al. (1984) J. Biol. Chem. 259, 14835-14839. 3 . Haas, A.L. et al. (1987) J. Biol. Chem. 262, 11315-11323. 4 . Knight, E. and Cordova, B. (1991) J. Immunol. 146, 2280-2284. 5 . DCunha, J. et al. (1996) Proc. Natl. Acad. Sci. USA 93, 211-215. 6 . Loeb, K.R. and Haas, A.L. (1992) J. Biol. Chem. 267, 7806-7813. 7 . Zhao, C. et al. (2005) Proc. Natl. Acad. Sci. USA 102, 10200-10205. 8 . Malakhov, M.P. et al. (2002) J. Biol. Chem. 277, 9976-9981. 9 . Malakhov, M.P. et al. (2003) J. Biol. Chem. 278, 16608-16613. 10 . Hamerman, J.A. et al. (2002) J. Immunol. 168, 2415-2423. 11 . Malakhova, O.A. et al. (2003) Genes Dev. 17, 455-460. 12 . McLaughlin, P.M. et al. (2000) Int J Cancer 85, 871-6. 13 . Kok, K. et al. (1995) Gene Expr 4, 163-75. 14 . Pitha-Rowe, I. et al. (2004) Cancer Res 64, 8109-15. 15 . Feng, Q. et al. (2008) Mol Cancer Ther 7, 3780-8. 16 . Shah, S.J. et al. (2008) Mol Cancer Ther 7, 905-14. 17 . Kitareewan, S. et al. (2002) Proc Natl Acad Sci U S A 99, 3806-11. |
Western blot analaysis of extracts from various cell lines using UBE1L/UBA7 (D6U4S) Rabbit mAb. | |
Western blot analysis of extracts from 293T cells, mock transfected (-) or transfected with constructs expressing Myc/DDK-tagged full-length human UBE1 protein (hUBE1-Myc/DDK; +), Myc/DDK-tagged full-length human UBE1L2 protein (hUBE1L2-Myc/DDK; +) and Myc/DDK-tagged full-length human UBE1L protein (hUBE1L-Myc/DDK; +), using UBE1L/UBA7 (D6U4S) Rabbit mAb (upper) and DYKDDDDK Tag Antibody #2368 (lower). |
